Gilead Sciences, Inc. is an American biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines. The company primarily focuses on antiviral drugs for life-threatening conditions such as HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. Recently, Gilead has expanded its therapeutic areas to include oncology and inflammation, aiming to address unmet medical needs globally.